GlassScriptPhysician profile
Rachel Grinnan
NPI 1215383815
$5,101.26
in general payments reported to CMS, 2019-2025
20 companies · $3,066 in 2025
The $3,066 reported for 2025 was more than what 78% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,036 · 2025: $3,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,897 · Travel and Lodging: $1,784 · Education: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.93 |
| Travel and Lodging | $1,784.33 |
| Education | $420.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,255.25 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Philips North America LLC | $1,095.08 | 2025 | Igt Devices Undivided, IV Other |
| Stryker Corporation | $636.58 | 2025 | Artix Mt |
| Medtronic, INC. | $463.85 | 2024-2025 | Endurant Iis, Unid_pass |
| Penumbra, INC. | $273.55 | 2025 | Indigo System |
| Inspiremd LTD | $196.83 | 2025 | Cguard Prime Carotid Stent System |
| Cook Medical LLC | $190.37 | 2024 | Zenith Alpha, Zenith Spiral-Z |
| W. L. Gore & Associates, INC. | $150.53 | 2024 | Gore Tag Conformable Thoracic Endoprosthesis |
| Shockwave Medical, INC | $140.34 | 2025 | |
| Boston Scientific Corporation | $132.44 | 2025 | General - Vascular Intervention, General - Thrombectomy |
| Corcept Therapeutics | $124.98 | 2025 | Korlym |
| Abiomed | $118.65 | 2025 | |
| Acera Surgical, INC. | $69.59 | 2025 | Restrata Wound Matrix |
| Endologix LLC | $68.21 | 2025 | Torus Stent Graft System, Endocross Device |
| Integra Lifesciences Corporation | $63.23 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $37.08 | 2025 | Stimulan |
| Actelion Pharmaceuticals US, INC. | $22.66 | 2025 | Opsumit, Uptravi |
| Angiodynamics, INC. | $22.15 | 2025 | Auryon Laser System 100-120 Vac |
| Imperative Care, INC | $20.31 | 2025 | Hotshot Controller |
| Astrazeneca Pharmaceuticals LP | $19.58 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Grinnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.